MARIMO cells harbor a CALR mutation but are not dependent on JAK2/STAT5 signaling

被引：32

作者：

Kollmann, K. ^{[1
,2
]}

Nangalia, J. ^{[1
,2
,3
,4
]}

Warsch, W. ^{[1
,2
]}

Quentmeier, H. ^{[5
]}

Bench, A. ^{[4
]}

Boyd, E. ^{[4
]}

Scott, M. ^{[4
]}

Drexler, H. G. ^{[5
]}

Green, A. R. ^{[1
,2
,4
]}

机构：

[1] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Cambridge Inst Med Res, Cambridge, England

[2] Univ Cambridge, Dept Haematol, Cambridge, England

[3] Wellcome Trust Sanger Inst, Cambridge, England

[4] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England

[5] German Collect Microorganisms & Cell Cultures, Leibniz Inst DSMZ, Braunschweig, Germany

来源：

LEUKEMIA | 2015年 / 29卷 / 02期

关键词：

MYELOPROLIFERATIVE NEOPLASMS; ESSENTIAL THROMBOCYTHEMIA; MYELOFIBROSIS; RETICULUM; JAK2; CALRETICULIN; INHIBITOR;

D O I：

10.1038/leu.2014.285

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：494 / 497

页数：5

共 16 条

[1] CALR mutations in myeloproliferative neoplasms: Hidden behind the reticulum [J].

Guglielmelli, Paola ;

Nangalia, Jyoti ;

Green, Anthony R. ;

Vannucchi, Alessandro M. .

AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (05) :453-456

[2] Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemia [J].

Harrison, Claire N. ;

Butt, Nauman ;

Campbell, Peter ;

Conneally, Eibhlin ;

Drummond, Mark ;

Green, Anthony R. ;

Murrin, Richard ;

Radia, Deepti H. ;

Mead, Adam ;

Reilly, John T. ;

Cross, Nicholas C. P. ;

McMullin, Mary F. .

BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (03) :421-423

[3] Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms [J].

Klampfl, Thorsten ;

Gisslinger, Heinz ;

Harutyunyan, Ashot S. ;

Nivarthi, Harini ;

Rumi, Elisa ;

Milosevic, Jelena D. ;

Them, Nicole C. C. ;

Berg, Tiina ;

Gisslinger, Bettina ;

Pietra, Daniela ;

Chen, Doris ;

Vladimer, Gregory I. ;

Bagienski, Klaudia ;

Milanesi, Chiara ;

Casetti, Ilaria Carola ;

Sant'Antonio, Emanuela ;

Ferretti, Virginia ;

Elena, Chiara ;

Schischlik, Fiorella ;

Cleary, Ciara ;

Six, Melanie ;

Schalling, Martin ;

Schoenegger, Andreas ;

Bock, Christoph ;

Malcovati, Luca ;

Pascutto, Cristiana ;

Superti-Furga, Giulio ;

Cazzola, Mario ;

Kralovics, Robert .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (25) :2379-2390

[4] Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum [J].

Michalak, Marek ;

Groenendyk, Jody ;

Szabo, Eva ;

Gold, Leslie I. ;

Opas, Michal .

BIOCHEMICAL JOURNAL, 2009, 417 :651-666

[5] Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2 [J].

Nangalia, J. ;

Massie, C. E. ;

Baxter, E. J. ;

Nice, F. L. ;

Gundem, G. ;

Wedge, D. C. ;

Avezov, E. ;

Li, J. ;

Kollmann, K. ;

Kent, D. G. ;

Aziz, A. ;

Godfrey, A. L. ;

Hinton, J. ;

Martincorena, I. ;

Van Loo, P. ;

Jones, A. V. ;

Guglielmelli, P. ;

Tarpey, P. ;

Harding, H. P. ;

Fitzpatrick, J. D. ;

Goudie, C. T. ;

Ortmann, C. A. ;

Loughran, S. J. ;

Raine, K. ;

Jones, D. R. ;

Butler, A. P. ;

Teague, J. W. ;

O'Meara, S. ;

McLaren, S. ;

Bianchi, M. ;

Silber, Y. ;

Dimitropoulou, D. ;

Bloxham, D. ;

Mudie, L. ;

Maddison, M. ;

Robinson, B. ;

Keohane, C. ;

Maclean, C. ;

Hill, K. ;

Orchard, K. ;

Tauro, S. ;

Du, M-Q ;

Greaves, M. ;

Bowen, D. ;

Huntly, B. J. P. ;

Harrison, C. N. ;

Cross, N. C. P. ;

Ron, D. ;

Vannucchi, A. M. ;

Papaemmanuil, E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (25) :2391-2405

[6]

Passamonti F, 2014, NEW ENGL J MED, V370, P1168, DOI 10.1056/NEJMc1400499

[7] Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia [J].

Puigdecanet, E. ;

Espinet, B. ;

Lozano, J. J. ;

Sumoy, L. ;

Bellosillo, B. ;

Arenillas, L. ;

Alvarez-Larran, A. ;

Sole, F. ;

Serrano, S. ;

Besses, C. ;

Florensa, L. .

LEUKEMIA, 2008, 22 (07) :1368-1376

[8] Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis [J].

Rampal, Raajit ;

Al-Shahrour, Fatima ;

Abdel-Wahab, Omar ;

Patel, Jay P. ;

Brunel, Jean-Philippe ;

Mermel, Craig H. ;

Bass, Adam J. ;

Pretz, Jennifer ;

Ahn, Jihae ;

Hricik, Todd ;

Kilpivaara, Outi ;

Wadleigh, Martha ;

Busque, Lambert ;

Gilliland, D. Gary ;

Golub, Todd R. ;

Ebert, Benjamin L. ;

Levine, Ross L. .

BLOOD, 2014, 123 (22) :E123-E133

[9] Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012 [J].

Reilly, John T. ;

McMullin, Mary Frances ;

Beer, Philip A. ;

Butt, Nauman ;

Conneally, Eibhlin ;

Duncombe, Andrew S. ;

Green, Anthony R. ;

Mikhaeel, George ;

Gilleece, Marie H. ;

Knapper, Steven ;

Mead, Adam J. ;

Mesa, Ruben A. ;

Sekhar, Mallika ;

Harrison, Claire N. .

BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (03) :418-420

[10] JAK2V617F-negative ET patients do not display constitutively active JAK/STAT signaling [J].

Schwernmers, Sven ;

Will, Britta ;

Waller, Cornelius E. ;

Abdulkarim, Khadija ;

Johansson, Peter ;

Andreasson, Bjorn ;

Pahl, Heike L. .

EXPERIMENTAL HEMATOLOGY, 2007, 35 (11) :1695-1703

← 1 2 →